Algorithm accurately predicts Alzheimer’s risk, study finds
By
Alicia Lasek
May 05, 2020
A computer algorithm can go head-to-head with neurologists, accurately diagnosing Alzheimer’s disease and predicting risk, say investigators.
Largest-ever Alzheimer’s study unlocks new knowledge about the disease’s genetic roots, researchers...
By
Tim Mullaney
Oct 30, 2013
The largest-ever international study of Alzheimer’s disease has significantly expanded the scientific community’s understanding of the disease’s genetic underpinnings, according to a...
Drug cures Alzheimer’s symptoms in mice, Yale researchers find
By
Stephanie H. Kim
Aug 07, 2014
A drug compound successfully reversed the effects of Alzheimer’s disease in mice, researchers say, giving hope to developers trying to find a cure.
Lawmakers should weigh costs associated with dementia when coordinating care for Medicare beneficiaries,...
By
McKnight's Staff
May 17, 2012
As policymakers seek to integrate care for dual eligibles, they need to consider the cost of treating beneficiaries with dementia, new data suggests.
Gait speed slows long before dementia diagnosis, 15-year study finds
By
Alicia Lasek
Feb 11, 2022
Slowing gait speed may signal the onset of dementia up to nine years before cognitive decline becomes evident, investigators say. It’s also linked to Alzheimer’s-related brain changes.
NIA set to build $300M ‘real world’ Alzheimer’s database
By
Alicia Lasek
Apr 06, 2023
The goal is to collect real-world data on Alzheimer’s disease and create a centralized data hub, helping to expand and speed Alzheimer’s research.
Avoid antipsychotic use to lessen stroke risk in Alzheimer’s patients: study
By
Alicia Lasek
Oct 29, 2021
The increased odds of experiencing a stroke within 60 days of starting treatment suggests that even short-term antipsychotic use should be avoided if possible, investigators contend.
Alzheimer’s signs may be evident decades before onset: Family history is key
By
Alicia Lasek
Jun 23, 2019
Signs of Alzheimer’s disease may show up four decades before onset, according to a web-based study of 60,000 individuals.
FDA advisers vote ‘no’ on drug that may slow Alzheimer’s progression
By
Alicia Lasek
Nov 09, 2020
If approved by the FDA, aducanumab would be the first-ever drug marketed to slow progression of the brain-wasting disease, according to its developer. But an advisory committee was unconvinced of the drug’s...
Study: ‘Cognitive frailty’ may be result of aging — not the brain changes found in dementia
By
Alicia Lasek
Jan 11, 2022
Reduced cognitive function without substantial memory complaints may be a normal part of aging and not an early sign of Alzheimer’s disease or other dementias, investigators say.